Title |
Assessment of vaccine candidates for persons aged 50 and older: a review
|
---|---|
Published in |
BMC Geriatrics, April 2013
|
DOI | 10.1186/1471-2318-13-32 |
Pubmed ID | |
Authors |
Renske Eilers, Paul FM Krabbe, Ted GA van Essen, Anita Suijkerbuijk, Alies van Lier, Hester E de Melker |
Abstract |
The increasing life expectancy in most European countries has resulted in growth of the population 50 and older. This population is more susceptible to infectious diseases because of immunosenescence, co-morbidity and general frailty. Thus, to promote healthy aging, vaccination against vaccine-preventable-diseases could be one strategy. In addition to its possible individual benefits, vaccination may also yield social benefits, such as a lower overall cost of healthcare. Most European countries, however, offer only influenza vaccine although vaccines for pneumococcal disease, herpes zoster, pertussis, and hepatitis A are also available. Our aim is to review the knowledge of these vaccines for persons aged 50 and older and explore the arguments for expanding current vaccination programmes beyond just influenza. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 2 | 67% |
Members of the public | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 1% |
Austria | 1 | 1% |
Unknown | 81 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 16% |
Student > Master | 13 | 16% |
Student > Ph. D. Student | 11 | 13% |
Student > Postgraduate | 6 | 7% |
Student > Bachelor | 5 | 6% |
Other | 16 | 19% |
Unknown | 19 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 25% |
Agricultural and Biological Sciences | 10 | 12% |
Economics, Econometrics and Finance | 5 | 6% |
Nursing and Health Professions | 4 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
Other | 14 | 17% |
Unknown | 25 | 30% |